Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Asset Utilization Ratio: 2013-2025

Historic Asset Utilization Ratio for Agios Pharmaceuticals (AGIO) over the last 11 years, with Sep 2025 value amounting to 0.03.

  • Agios Pharmaceuticals' Asset Utilization Ratio rose 22.33% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year increase of 22.33%. This contributed to the annual value of 0.03 for FY2024, which is 13.86% up from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Asset Utilization Ratio of 0.03 as of Q3 2025, which was up 16.09% from 0.03 recorded in Q2 2025.
  • Agios Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.08 during Q1 2022, with a 5-year trough of 0.01 in Q4 2022.
  • Its 3-year average for Asset Utilization Ratio is 0.03, with a median of 0.03 in 2024.
  • Data for Agios Pharmaceuticals' Asset Utilization Ratio shows a peak YoY increase of 134.35% (in 2023) and a maximum YoY decrease of 81.13% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Agios Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2022, then skyrocketed by 134.35% to 0.03 in 2023, then fell by 23.42% to 0.02 in 2024, then increased by 22.33% to 0.03 in 2025.
  • Its Asset Utilization Ratio was 0.03 in Q3 2025, compared to 0.03 in Q2 2025 and 0.02 in Q1 2025.